Diagnosticos da America SA (DASA3.SA) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Diagnosticos da America SA announces approval of CADE for acquisition of control by Cromossomo Participacoes II SA


Thursday, 17 Jul 2014 08:17am EDT 

Diagnosticos da America SA:Says on July 16 the Administrative Council for Economic Defense (CADE) approved acquisition of ordinary shares of the company by Cromossomo Participacoes II SA (Cromossomo).This results in that Edson de Godoy Bueno and Dulce Pugliese de Godoy Bueno (indirectly holding entire share capital of Cromossomo) will control, directly or indirectly, over 70 percent stake in the company. 

Company Quote

10.4
-0.15 -1.42%
24 Jun 2016